Candriam SCA’s Aceragen Inc ACGN Stock Holding History

Candriam SCA’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,076	Closed	-$740K	–	846
2019 Q1	$740K	Hold	17,076	–	–	0.01%	674
2018 Q4	$803K	Buy	17,076 +5,594	+49%	+$643K	0.01%	627
2018 Q3	$1.74M	Buy	+11,482	New	+$1.64M	0.02%	533

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Candriam SCA's ACGN Position: Q2 2019 in Review

Candriam SCA sold out of Aceragen Inc (ACGN) in Q2 2019, closing a stake of 17,076 shares — an estimated $740K sold.

Candriam SCA first reported a position in ACGN in Q3 2018 and held it in 3 quarters. The position peaked at $1.74M in Q3 2018. 56 funds tracked by Wall St. Rank hold ACGN as of Q2 2019.

Candriam SCA reported no remaining Aceragen Inc position as of Q2 2019 after selling out during the quarter.
Candriam SCA sold 17,076 Aceragen Inc shares in Q2 2019, an estimated $740K.
Candriam SCA first reported a position in Aceragen Inc in Q3 2018 and held it in 3 quarters.
Candriam SCA's Aceragen Inc position peaked at $1.74M in Q3 2018.
56 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2019.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.